A Trial to Evaluate the Safety and Efficacy of PS433540 to Treat Hypertension
Public ClinicalTrials.gov record NCT00522925. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of a Novel Dual Angiotensin and Endothelin Receptor Antagonist (PS433540) in Subjects With Stage I and II Hypertension
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to see if PS433540 lowers blood pressure better than placebo and to see how safe PS433540 is compared to placebo.
Study identification
- NCT ID
- NCT00522925
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 280 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 30 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2007 (Type not available)
- Primary completion
- Apr 2008 (Actual)
- Completion
- May 2008 (Actual)
- Last update posted
- Sep 16, 2011
2007 – 2008
United States locations
- U.S. sites
- 15
- U.S. states
- 8
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Premiere Pharmaceutical Research, LLC | Tempe | Arizona | 85282 | — |
| Clinical Trials Research | Lincoln | California | 95648 | — |
| Long Beach Center for Clinical Research | Long Beach | California | 90806 | — |
| National Research Institute | Los Angeles | California | 90057 | — |
| Sacramento Research Medical Group | Sacramento | California | 95825 | — |
| Orange County Research Center | Tustin | California | 92780 | — |
| Westlake Medical Center | Westlake Village | California | 91361 | — |
| University Clinical Research Deland, LLC | DeLand | Florida | 32720 | — |
| Alan Graff, MD PA | Fort Lauderdale | Florida | 33308 | — |
| Cedar Crosse Research Center | Chicago | Illinois | 60607 | — |
| Orland Primary Care Specialists | Orland Park | Illinois | 60467 | — |
| MD Medical Research | Oxon Hill | Maryland | 20745 | — |
| Lindner Clinical Trial Center | Cincinnati | Ohio | 45219 | — |
| Punzi Medical Center | Carrolton | Texas | 75006 | — |
| Gemini Scientific | Madison | Wisconsin | 53719 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00522925, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 16, 2011 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00522925 live on ClinicalTrials.gov.